ORIGINAL RESEARCH article
Front. Pediatr.
Sec. Pediatric Rheumatology
Volume 13 - 2025 | doi: 10.3389/fped.2025.1678064
Microvascular Changes in Children with MIS-C: A Monocentric Exploratory Study Using Comparative Nailfold Capillaroscopy
Provisionally accepted- 1Division of Pediatric Rheumatology, Department of Pediatrics, Erciyes University Faculty of Medicine, Erciyes Universitesi Tip Fakultesi, Kayseri, Türkiye
- 2Division of Pediatric Infectious Diseases, Department of Pediatrics, Erciyes University Faculty of Medicine, Kayseri, Turkey, Erciyes Universitesi Tip Fakultesi, Kayseri, Türkiye
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Multisystem Inflammatory Syndrome in Children (MIS-C) is a severe hyperinflammatory condition that arises after SARS-CoV-2 infection and may lead to endothelial dysfunction and microvascular damage. Despite increasing knowledge on systemic manifestations, microcirculatory involvement in MIS-C remains underexplored. Objective: To evaluate nailfold capillaroscopy (NFC) findings in children diagnosed with MIS-C and compare them with age-and sex-matched healthy controls, thereby assessing subclinical microvascular alterations associated with MIS-C. Methods: In this cross-sectional study, 25 MIS-C patients meeting CDC criteria and 29 age-/sex-matched controls underwent standardized NFC at 200× magnification by a blinded examiner. Eight fingers (excluding thumbs) were imaged. Morphological parameters (tortuosity, crossing, dilatation, neoangiogenesis, etc.) and quantitative measures (capillary density, lengths, widths, intercapillary distance) were recorded. Tortuosity and crossing were scored semi-quantitatively (0: absent; 1: <50% affected; 2: >50% affected). Between-group comparisons used Mann–Whitney U and Chi-square/Fisher tests (α=0.05). Results: MIS-C patients had higher rates of tortuosity (92.0% vs 62.1%, p=0.010), crossing (64.0% vs 27.6%, p=0.007) and dilated capillaries (16.0% vs 0%, p=0.040). Apical loop width was reduced (median 12 vs 14 µm, p<0.001) and disorganization score increased (p=0.020). Semiquantitative scores were higher for tortuosity (p=0.002), crossing (p=0.003) and dilatation (p=0.027) in MIS-C. No meandering, giant capillaries, avascular areas or microhemorrhages were observed. Conclusion: Nailfold capillaroscopy revealed notable microvascular alterations in children with MIS-C, including increased tortuosity, dilated capillaries, and disorganization. These findings suggest that NFC may serve as a useful non-invasive tool for detecting endothelial dysfunction and early microvascular involvement in MIS-C. Importantly, given the current rarity of MIS-C cases in the post-pandemic era, this study provides a unique and timely contribution, offering one of the few systematic evaluations of microvascular alterations in pediatric MIS-C and establishing a valuable reference point for future comparative research in pediatric vasculopathies.
Keywords: MIS-C, COVID-19, Children, Nailfold capillaroscopy, Microvascular damage, endothelialdysfunction
Received: 01 Aug 2025; Accepted: 30 Sep 2025.
Copyright: © 2025 Taşkın, Doğantan, Esen, Sarı, Çetin, Pac Kisaarslan and Poyrazoğlu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence: Sema Nur Taşkın, sntistanbul@gmail.com
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.